HU198086B - Process for producing immunostimulatn acyl-tripeptides - Google Patents
Process for producing immunostimulatn acyl-tripeptides Download PDFInfo
- Publication number
- HU198086B HU198086B HU851217A HU121785A HU198086B HU 198086 B HU198086 B HU 198086B HU 851217 A HU851217 A HU 851217A HU 121785 A HU121785 A HU 121785A HU 198086 B HU198086 B HU 198086B
- Authority
- HU
- Hungary
- Prior art keywords
- mmol
- solution
- acid
- stirred
- evaporated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/16—Eight-membered rings
- C07D313/18—Eight-membered rings not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/595,169 US4565653A (en) | 1984-03-30 | 1984-03-30 | Acyltripeptide immunostimulants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUT37443A HUT37443A (en) | 1985-12-28 |
| HU198086B true HU198086B (en) | 1989-07-28 |
Family
ID=24382038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU851217A HU198086B (en) | 1984-03-30 | 1985-03-29 | Process for producing immunostimulatn acyl-tripeptides |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4565653A (enExample) |
| EP (1) | EP0157572A3 (enExample) |
| JP (1) | JPS60224699A (enExample) |
| KR (1) | KR870000372B1 (enExample) |
| AU (2) | AU552919B2 (enExample) |
| CA (1) | CA1270098A (enExample) |
| DD (1) | DD239406A5 (enExample) |
| DK (1) | DK142485A (enExample) |
| EG (1) | EG17928A (enExample) |
| ES (1) | ES8605821A1 (enExample) |
| FI (1) | FI851271L (enExample) |
| GR (1) | GR850783B (enExample) |
| HU (1) | HU198086B (enExample) |
| IL (1) | IL74758A (enExample) |
| NO (1) | NO851278L (enExample) |
| NZ (1) | NZ211634A (enExample) |
| PH (1) | PH21303A (enExample) |
| PL (1) | PL252659A1 (enExample) |
| PT (1) | PT80181B (enExample) |
| ZA (1) | ZA852335B (enExample) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1295784C (en) * | 1985-11-25 | 1992-02-11 | James Patrick Rizzi | Peptide immunostimulants |
| JPH0718039B2 (ja) * | 1986-03-26 | 1995-03-01 | 株式会社豊田自動織機製作所 | 粉末付加亜鉛めっき鋼板の製造方法 |
| FI890886A7 (fi) * | 1986-08-27 | 1989-02-24 | Pfizer | Kiteinen N-(S-3-metyyliheptanoyyli)-D-gamma-glutamyyli-glysyyli-D-alan iini ja menetelmiä sen valmistamiseksi sekä välituotteita |
| WO1988001612A1 (en) * | 1986-08-27 | 1988-03-10 | Pfizer Inc. | Processes and intermediates for n-(s-3-alkyl-heptanoyl)-d-gamma-glutamyl-glycyl-d-alanine |
| DE3700173A1 (de) * | 1987-01-05 | 1988-07-14 | Hoechst Ag | Verfahren zur herstellung von lipophilen aminosaeurederivaten sowie lipophile aminosaeurederivate |
| DE3820528A1 (de) * | 1988-06-16 | 1989-12-21 | Bayer Ag | Mittel zur insekten- und milbenabwehr |
| US5245079A (en) * | 1989-02-21 | 1993-09-14 | Pfizer Inc. | Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine |
| US5136020A (en) * | 1989-02-21 | 1992-08-04 | Pfizer Inc. | Crystalline n-(s-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor |
| US5248820A (en) * | 1989-02-21 | 1993-09-28 | Pfizer Inc. | Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor |
| US5185464A (en) * | 1989-02-21 | 1993-02-09 | Pfizer Inc. | Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor |
| US5134225A (en) * | 1989-02-21 | 1992-07-28 | Pfizer Inc. | Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-D-alanine |
| US5798387A (en) * | 1992-10-15 | 1998-08-25 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Amino acid derivatives |
| DE69326321T2 (de) | 1992-10-15 | 2000-01-13 | Kanegafuchi Kagaku Kogyo K.K., Osaka | Neues aminosäurederivat |
| US5545553A (en) * | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| US7157277B2 (en) * | 2001-11-28 | 2007-01-02 | Neose Technologies, Inc. | Factor VIII remodeling and glycoconjugation of Factor VIII |
| US7399613B2 (en) * | 2001-10-10 | 2008-07-15 | Neose Technologies, Inc. | Sialic acid nucleotide sugars |
| US7696163B2 (en) | 2001-10-10 | 2010-04-13 | Novo Nordisk A/S | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| US7795210B2 (en) * | 2001-10-10 | 2010-09-14 | Novo Nordisk A/S | Protein remodeling methods and proteins/peptides produced by the methods |
| US7173003B2 (en) * | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
| US8008252B2 (en) * | 2001-10-10 | 2011-08-30 | Novo Nordisk A/S | Factor VII: remodeling and glycoconjugation of Factor VII |
| US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| DE60336555D1 (de) * | 2002-06-21 | 2011-05-12 | Novo Nordisk Healthcare Ag | Pegylierte glykoformen von faktor vii |
| NZ542094A (en) * | 2003-03-14 | 2008-12-24 | Neose Technologies Inc | Branched polymer conjugates comprising a peptide and water-soluble polymer chains |
| US8791070B2 (en) | 2003-04-09 | 2014-07-29 | Novo Nordisk A/S | Glycopegylated factor IX |
| US20070026485A1 (en) | 2003-04-09 | 2007-02-01 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| US20080146782A1 (en) * | 2006-10-04 | 2008-06-19 | Neose Technologies, Inc. | Glycerol linked pegylated sugars and glycopeptides |
| EP1613261A4 (en) * | 2003-04-09 | 2011-01-26 | Novo Nordisk As | INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES |
| BRPI0410164A (pt) | 2003-05-09 | 2006-05-16 | Neose Technologies Inc | composições e métodos para preparação de mutantes de glicosilação de hormÈnio do crescimento humano |
| WO2005012484A2 (en) | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Antibody-toxin conjugates |
| US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
| US8633157B2 (en) * | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
| EP1694347B1 (en) * | 2003-11-24 | 2013-11-20 | BioGeneriX AG | Glycopegylated erythropoietin |
| US20080318850A1 (en) * | 2003-12-03 | 2008-12-25 | Neose Technologies, Inc. | Glycopegylated Factor Ix |
| US20070254836A1 (en) * | 2003-12-03 | 2007-11-01 | Defrees Shawn | Glycopegylated Granulocyte Colony Stimulating Factor |
| US7956032B2 (en) * | 2003-12-03 | 2011-06-07 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
| US20060040856A1 (en) * | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
| WO2005070138A2 (en) * | 2004-01-08 | 2005-08-04 | Neose Technologies, Inc. | O-linked glycosylation of peptides |
| WO2006010143A2 (en) | 2004-07-13 | 2006-01-26 | Neose Technologies, Inc. | Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] |
| US8268967B2 (en) * | 2004-09-10 | 2012-09-18 | Novo Nordisk A/S | Glycopegylated interferon α |
| ES2566670T3 (es) * | 2004-10-29 | 2016-04-14 | Ratiopharm Gmbh | Remodelación y glucopegilación del factor de crecimiento de fibroblastos (FGF) |
| JP2008526864A (ja) * | 2005-01-06 | 2008-07-24 | ネオス テクノロジーズ インコーポレイテッド | 糖断片を用いる糖結合 |
| JP4951527B2 (ja) * | 2005-01-10 | 2012-06-13 | バイオジェネリックス アーゲー | 糖peg化顆粒球コロニー刺激因子 |
| US20060246544A1 (en) * | 2005-03-30 | 2006-11-02 | Neose Technologies,Inc. | Manufacturing process for the production of peptides grown in insect cell lines |
| US20070154992A1 (en) * | 2005-04-08 | 2007-07-05 | Neose Technologies, Inc. | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
| WO2006127910A2 (en) * | 2005-05-25 | 2006-11-30 | Neose Technologies, Inc. | Glycopegylated erythropoietin formulations |
| EP2975135A1 (en) * | 2005-05-25 | 2016-01-20 | Novo Nordisk A/S | Glycopegylated factor IX |
| CA2619969A1 (en) * | 2005-08-19 | 2007-02-22 | Neose Technologies, Inc. | Glycopegylated factor vii and factor viia |
| US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
| US20090048440A1 (en) * | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes |
| US20080248959A1 (en) * | 2006-07-21 | 2008-10-09 | Neose Technologies, Inc. | Glycosylation of peptides via o-linked glycosylation sequences |
| EP2054521A4 (en) * | 2006-10-03 | 2012-12-19 | Novo Nordisk As | PROCESS FOR CLEANING POLYPEPTIDE CONJUGATES |
| US20080207487A1 (en) * | 2006-11-02 | 2008-08-28 | Neose Technologies, Inc. | Manufacturing process for the production of polypeptides expressed in insect cell-lines |
| PL2144923T3 (pl) * | 2007-04-03 | 2013-12-31 | Biogenerix Ag | Sposoby leczenia z użyciem glikopegilowanego G-CSF |
| US20090053167A1 (en) * | 2007-05-14 | 2009-02-26 | Neose Technologies, Inc. | C-, S- and N-glycosylation of peptides |
| WO2008151258A2 (en) * | 2007-06-04 | 2008-12-11 | Neose Technologies, Inc. | O-linked glycosylation using n-acetylglucosaminyl transferases |
| EP2170919B8 (en) * | 2007-06-12 | 2016-01-20 | ratiopharm GmbH | Improved process for the production of nucleotide sugars |
| US8207112B2 (en) * | 2007-08-29 | 2012-06-26 | Biogenerix Ag | Liquid formulation of G-CSF conjugate |
| CN102037004A (zh) * | 2008-01-08 | 2011-04-27 | 生物种属学股份公司 | 使用寡糖基转移酶的多肽的糖缀合 |
| EP2626079A3 (en) | 2008-02-27 | 2014-03-05 | Novo Nordisk A/S | Conjungated factor VIII molecules |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4322341A (en) * | 1980-05-13 | 1982-03-30 | Fujisawa Pharmaceutical Co | Peptide, process for preparation thereof and use thereof |
| DK156252C (da) * | 1979-07-31 | 1989-12-18 | Fujisawa Pharmaceutical Co | Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf |
| EP0027260B1 (en) * | 1979-10-11 | 1985-03-13 | Fujisawa Pharmaceutical Co., Ltd. | Peptides, processes for their preparation and pharmaceutical compositions containing them |
| GR81332B (enExample) * | 1980-12-01 | 1984-12-11 | Fujisawa Pharmaceutical Co | |
| US4493794A (en) * | 1980-12-31 | 1985-01-15 | Fujisawa Pharmaceutical Co., Ltd. | Peptide, process for preparation thereof and use thereof |
-
1984
- 1984-03-30 US US06/595,169 patent/US4565653A/en not_active Expired - Fee Related
-
1985
- 1985-03-26 PH PH32046A patent/PH21303A/en unknown
- 1985-03-26 EP EP85302065A patent/EP0157572A3/en not_active Withdrawn
- 1985-03-27 ES ES541620A patent/ES8605821A1/es not_active Expired
- 1985-03-28 EG EG201/85A patent/EG17928A/xx active
- 1985-03-28 ZA ZA852335A patent/ZA852335B/xx unknown
- 1985-03-28 GR GR850783A patent/GR850783B/el unknown
- 1985-03-28 DD DD85274551A patent/DD239406A5/de not_active IP Right Cessation
- 1985-03-28 PT PT80181A patent/PT80181B/pt not_active IP Right Cessation
- 1985-03-28 CA CA000477796A patent/CA1270098A/en not_active Expired - Lifetime
- 1985-03-29 IL IL74758A patent/IL74758A/xx unknown
- 1985-03-29 JP JP60066380A patent/JPS60224699A/ja active Pending
- 1985-03-29 HU HU851217A patent/HU198086B/hu unknown
- 1985-03-29 AU AU40523/85A patent/AU552919B2/en not_active Ceased
- 1985-03-29 DK DK142485A patent/DK142485A/da not_active Application Discontinuation
- 1985-03-29 KR KR1019850002106A patent/KR870000372B1/ko not_active Expired
- 1985-03-29 NO NO851278A patent/NO851278L/no unknown
- 1985-03-29 NZ NZ211634A patent/NZ211634A/xx unknown
- 1985-03-29 PL PL25265985A patent/PL252659A1/xx unknown
- 1985-03-29 FI FI851271A patent/FI851271L/fi not_active Application Discontinuation
-
1986
- 1986-04-22 AU AU56476/86A patent/AU566460B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| PH21303A (en) | 1987-09-28 |
| PL252659A1 (en) | 1985-11-19 |
| AU5647686A (en) | 1986-09-04 |
| PT80181A (en) | 1985-04-01 |
| NZ211634A (en) | 1988-10-28 |
| ES8605821A1 (es) | 1986-04-01 |
| AU566460B2 (en) | 1987-10-22 |
| ES541620A0 (es) | 1986-04-01 |
| DK142485A (da) | 1985-10-01 |
| IL74758A0 (en) | 1985-06-30 |
| ZA852335B (en) | 1986-11-26 |
| FI851271A0 (fi) | 1985-03-29 |
| GR850783B (enExample) | 1985-11-25 |
| HUT37443A (en) | 1985-12-28 |
| CA1270098A (en) | 1990-06-05 |
| KR850006939A (ko) | 1985-10-25 |
| FI851271A7 (fi) | 1985-10-01 |
| EG17928A (en) | 1991-08-30 |
| PT80181B (en) | 1987-03-20 |
| FI851271L (fi) | 1985-10-01 |
| NO851278L (no) | 1985-10-01 |
| US4565653A (en) | 1986-01-21 |
| AU4052385A (en) | 1985-10-03 |
| JPS60224699A (ja) | 1985-11-09 |
| AU552919B2 (en) | 1986-06-26 |
| DK142485D0 (da) | 1985-03-29 |
| KR870000372B1 (ko) | 1987-03-06 |
| EP0157572A3 (en) | 1987-01-07 |
| EP0157572A2 (en) | 1985-10-09 |
| DD239406A5 (de) | 1986-09-24 |
| IL74758A (en) | 1988-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU198086B (en) | Process for producing immunostimulatn acyl-tripeptides | |
| US5633280A (en) | Urethanes and ureas that induce cytokine production | |
| US4816560A (en) | Partially retro-inverted tuftsin analogues, method for the preparation thereof and pharmaceutical compositions containing them | |
| KR870000810B1 (ko) | 펩타이드-치환된 헤테로사이클릭 화합물의 제조방법 | |
| JPH0647599B2 (ja) | ヘプタノイル―Glu―Asp―Ala―アミノ酸系免疫賦活薬 | |
| US5089476A (en) | Glutamic acid derivatives | |
| GB1582420A (en) | Phenylamino phenylacetic acid amide compounds and processes for their preparation | |
| US4767743A (en) | Peptide immunostimulants | |
| EP0227306B1 (en) | Peptide immunostimulants | |
| US6180759B1 (en) | Process for the preparation of azacycloalkylakanoyl pseudotetrapeptides | |
| KR900004648B1 (ko) | 펩타이드 유도체의 제조방법 | |
| US4497729A (en) | Peptide, process for preparation thereof and use thereof | |
| HU188110B (en) | Process for producing new tripeptide-derivatives | |
| EP0050856B1 (en) | New peptide, process for its preparation and pharmaceutical composition containing it | |
| US5108990A (en) | Glutamic acid derivatives | |
| CN85102340A (zh) | 制备免疫刺激剂酰三肽的方法 | |
| HU185978B (en) | Process for preparing new tetrapeptide derivatives | |
| JPH07119233B2 (ja) | 生理活性物質プロベスチンの合成法 | |
| JPS62234092A (ja) | 新規グルコ−ス誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HU90 | Patent valid on 900628 |